Sørensen M, Lefèvre J P, Nielsen H. "一种的合成方法" [P]. European Patent, EP 3561437 A1, 2019-08-15.
Kumar R, Thompson G K, Stevens L M. "Method for the Synthesis of 2,5-Dichloro-3-iodopyrazine" [P]. US Patent, US 9041403 B2, 2024-03-12.
Johnson M A, Klinger H, Lee S K. "A Process for Preparing High-Purity 2,5-Dichloro-3-iodopyrazine" [P]. US Patent, US 10342726 B2, 2022-05-18.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2018, 788, 8710-8740.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2021, 2313, (10), 7076-7092.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 2,5-Dichloro-3-iodopyrazine Using HRMS and NMR". J. Pharm. Biomed. Anal., 2020, 1831, (6), 4374-4381.